Skip to contents
 The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

INFORMATION FOR THE PUBLIC

Facts About ALLHAT

INFORMATION FOR HEALTH PROFESSIONALS

Quick Reference for Health
Care Providers

JAMA Articles

ALLHAT Study Web Site

MEDIA AND PRESS MATERIALS

Press Release: December 17, 2002

Press Release: April 5, 2005

Press Release: June 27, 2005

NHLBI Media Kit

ADDITIONAL RESOURCES

Your Guide to Lowering High
Blood Pressure

Live Healthier, Live
Longer (Cholesterol)

Aim for a Healthy Weight

NHLBI Resources for Patients
and the Public

High Blood Pressure
(National Library of Medicine
MEDLINE PLUS)

Cholesterol (National Library of Medicine MEDLINE PLUS)

 

Many drugs have been developed in recent years to treat high blood pressure (or hypertension) and high cholesterol, two major risk factors for heart disease. Recent findings from ALLHAT—the "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial"—a major clinical study supported by the National Heart, Lung, and Blood Institute (NHLBI), offer new information about treating both conditions.
















 Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute   

NHLBI Privacy Statement | NHLBI Accessibility Policy
ALLHAT Home | Contact | NHLBI Home | NIH Home

Please send us your feedback, comments, and questions
by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.
Link to DHHS Home Link to NIH Home Link to NHLBI Home